The human uniqueness of HIV: Innate immunity and the viral Tat protein

Human Immunology

Volumn 60, Issue 8, 1999, Pages 631-639

  Rodman, Toby C ^a,b   Sullivan, James J ^a   Bai, Xu ^a   Winston, Ronald ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Inst for Hum Genet and Biochem   (Switzerland)

Author keywords

HIV Tat protein; Human immune factors; Natural antibodies; Tolerance suppression

Indexed keywords

TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CHIMPANZEE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION;

ANIMALS; GENE PRODUCTS, TAT; HAPLORHINI; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; PAN TROGLODYTES; RABBITS; SPECIES SPECIFICITY;

EID: 0032805995     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00052-X     Document Type: Article

References (47)

1. McCune J.M. Animal models of HIV-1 disease. Science. 279:1997;2141.
2. Letvin N.L. Progress in the development of an HIV-1 vaccine. Science. 280:1998;1875.
3. Korth M.J., Taylor M.D., Katze M.G. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by different mechanisms. Virology. 2471:1998;265.
4. Janeway C.R. Jr. The road less traveled by the role of innate immunity in the adaptive immune response. Presidential address to the American Association of Immunologists . J Immunol. 161:1998;539.
5. Ehert A., Westendorf M.O., Herr I., Debatin K.M., Heeney J.L., Frank R., Kramer Ph. Resistance of Chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J Virol. 10:1996;6502.
6. Novembre F.J., Saucier M., Anderson D.C., Klumpp S.A., O'Neill S.P., Brown C.R. 2nd, Hart C.E., Guenther P.C., Swenson R.B., McClure R.M. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol. 71:1997;4086.
7. Rodman T.C., Pruslin F.H., To S.E., Winston R. Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope. J Exp Med. 175:1992;1247.
8. Rodman T.C., To S.E., Hashish H., Manchester K. Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein. Proc Natl Acad Sci USA. 90:1993;7719.
9. Rodman T.C., To S.E., Sullivan J.J., Winston R. Innate natural antibodies. Primary roles indicated by specific epitopes. Hum Immunol. 55:1997;87.
10. Frankel A.D., Biancalana S., Hudson D. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 86:1989;7397.
11. Kuppuswamy M., Subramanian T., Srinivasan A., Chinnadurai G. Multiple functional domains of Tat, the transactivator of HIV-1, defined by mutational analysis. Nucl Acids Res. 17:1989;3551.
12. Cullen B.R. Regulation of human immunodeficiency virus replication. Ann Rev Microbiol. 45:1991;219.
13. Crouau-Roy B., Service S., Slatkin M., Freimer N. A fine scale comparison of the human and chimpanzee genomes linkage disequilibrium and sequence analysis . Hum Mol Genet. 5:1996;1131.
14. Matzinger P. Tolerance, danger and the extended family. Ann Rev Immunol. 12:1994;991.
15. Brent L. The discovery of immunologic tolerance. Hum Immunol. 52:1997;75.
16. Van Parijis L., Abbas A.K. Homeostasis and self-tolerance in the immune system turning lymphocytes off . Science. 280:1998;243.
17. Korber B, Foley B, Leitner T, McCutchan P, Hahn B, Mellors JW, Myers G, Kruken C: Human Retroviruses and AIDS. Theoretical Biology and Biophysics Group T-10. Los Alamos National Laboratory. Los Alamos NM. 1997.
18. Pruslin F.H., To S.E., Winston R., Rodman T.C. Caveats and suggestions for the ELISA. J Immunol Meth. 137:1991;27.
19. + cell numbers reflects increase in HIV-1 replication. AIDS Res Hum Retroviruses. 4:1988;433.
20. Montefiori D.C., Pantaleo G., Fonk L.M., Zhou J.Y., Bilska M., Miralles G.D., Fauci A.S. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis. 173:1996;60.
21. Cao Y., Qin L., Zhang L., Safrit J., Ho D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 332:1995;201.
22. Coutinho A., Kazatchkine M.D., Avrameas S. Natural antibodies. Curr Opinon Immunol. 7:1995;812.
23. Parker W., Lundberg-Swanson K., Hoznecht Z.E., Lateef J., Washburn S.A., Braedhoeft S.J., Platt J.L. Isohemaglutinins and xenoreactive antibodies. Members of a distinct family of natural antibodies. Hum Immunol. 45:1996;94.
24. Carroll M.C., Prodeus A.P. Linkages of innate and adaptive immunity. Curr Opinion Immunol. 18:1998;36.
25. Palucka A., Banchereau J. Dendritic cells A link between innate and adaptive immunity . J Clin Immunol. 19:1999;12.
26. Jubier-Maurin V., Sarni-Marchado P., Vidal N., Bibollet-Ruche F., Durand J.P., Galat-Luong A., Cuny G. Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabeus). J Virol. 69:1995;7349.
27. Frankel A.D., Pabo C.O. Cellular uptake of the Tat protein from immunodeficiency virus. Cell. 55:1988;1189.
28. Mohri H., Bonkhoefer S., Monard S., Perelson A.S., Ho D.D. Rapid turnover of T lymphocytes in SIV-infected Rhesus Macaques. Science. 279:1998;1223.
29. 1998 Basic Science Symposium. Innate Immunity. Ancient Signals, Modern Implications. The New York Academy of Medicine.
30. Li C.J., Friedman D.J., Wang C., Metelev V., Pardee A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 268:1995;429.
31. New D.R., Ma M., Epstein L.G., Nath A., Gelhard H.A. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol. 3:1997;168.
32. New D.R., Maggirwar S.B., Epstein L.G., Dewhurst S., Gelhard H.A. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem. 273:1998;17852.
33. Shi B., Raino J., Lorenzo A., Busciglio J., Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia . J Neurovirol. 4:1998;281.
34. Cohen O.J., Kinter A., Fauci A.S. Host factors in the pathogenesis of HIV disease. Immunol Rev. 159:1997;31.
35. Gougeon M.L., Lecoer H., Boudet F., Ledru E., Marzabal S., Boullier S., Roue R., Nagata S., Heeney J. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol. 158:1997;2964.
36. +T lymphocytes is not mediated by Fas-Fas ligand. AIDS. 11:1998;1671.
37. +T cells by a Fas independent mechanism. J Exp Med. 187:1998;1113.
38. Iida T., Igarashi T., Ichimura H., Kwata T., Shimada T., Magamachi D., Yonehara S., Imanishi J., Hayami M. Fas antigen expression and apoptosis of lymphocytes in macaques infected with simian immunodeficiency virus strain mac 259. Arch Virol. 143:1998;717.
39. Samuelsson A., Brostrom C., Vandijk N., Sonnerborg A., Chiodi F. Apoptosis of CD4(+) and CD19(+) cells during human immunodeficiency virus Type 1 infection - correlation with clinical progression, viral load, and loss of humoral immunity. Virology. 238:1997;180.
40. Westergren I., Johansson B.B. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations a comparison between protamine, poly-L-lysine and poly-L-arginine . Acta Physiol Scand. 149:1993;99.
41. Melamed D., Benschop R.J., Cambier J.C., Nemanzee D. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell. 92:1998;173.
42. Rodman T.C., Laurence J., Pruslin F.H., Chiorazzi N., Winston R. Naturally occurring antibodies reactive with sperm proteins apparent deficiency in AIDS sera . Science. 228:1985;1211.
43. Rodman T.C., Winston R., Sullivan J.J., Yan X.J., Chiorazzi N. An innate natural antibody is reactive with a cryptic sequence of lactoferrin exposed on sperm head surface. Proc Soc Eptl Biol Med. 216:1997;404.
44. Messmer B.T., Sullivan J.J., Chiorazzi N., Rodman T.C., Thaler D. Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide evidence for a stereotyped repertoire of epitope recognition . J Immunol. 162:1999;2184.
45. Wang L., Radie M.Z., Galili U. Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol. 155:1995;1276.
46. Tierens A., Delabie J., Michiels L., Vandenberghe P., De Wolf-Peeters C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood. 93:1999;226.
47. Goldstein G. HIV-1 Tat protein as a potential AIDS vaccine. Nat Med. 2:1996;960.